Photo collage of Laura Bukavina and Phillip Abbosh
Jul 4, 2024, 13:06
Laura Bukavina: NTACT residual disease test presented by Phillip Abbosh
Laura Bukavina, Urologic Oncologist at Cleveland Clinic, shared on X:
“The NTACT residual disease test, eloquently presented by Phillip Abbosh published in JCO Precision Oncology. Remarkably, over 50% of patients without visible residual disease had positive mutations, indicative of field cancerization—mutations present in adjacent normal tissue WITHOUT cancer. NTACT demonstrated 91% sensitivity and 82% accuracy.”
Read further.
Source: Laura Bukavina/X